Items stated in the management plan
Partially revisedThe projected sales of the Chinese subsidiary declined as the recovery in the Chinese market slowed compared with the initial outlook. In addition, the full-scale adoption of the nanomaterials business's resources and materials, which had been expected in FY46, was postponed to FY47.
| Item | Details |
|---|---|
| Plan name | Mid-Term Management Plan 2026 |
| Plan period | Fiscal year ending March 2027 (FY47) through fiscal year ending March 2029 (FY49) |
| Progress against the plan | Partially revised |
| Sales Target | Not disclosed → ¥4,619 million |
| Operating profit target | Not disclosed → ¥352 million |
| Operating profit margin target | Not disclosed → 7.6 % |
| ROE target | Not disclosed → At least 8% |
| Payout ratio / DOE policy | The Company will return profits to stakeholders. Specific target levels and the applicable period for the dividend payout ratio and DOE are Not disclosed. |
| Self-assessment of PBR and share price | The Company will maintain a PBR of at least 1x and aims to achieve 2x or higher. The current PBR is Not disclosed. |
| Segment target | Segment Insulation materials / Sales Target Fiscal year ending March 2027 (FY47) ¥2,414 million / Fiscal year ending March 2028 (FY48) ¥2,677 million / Fiscal year ending March 2029 (FY49) ¥2,968 million / Profit Target Not disclosed, Segment Nanomaterials / Sales Target Fiscal year ending March 2027 (FY47) ¥528 million / Fiscal year ending March 2028 (FY48) ¥1,556 million / Fiscal year ending March 2029 (FY49) ¥1,651 million / Profit Target Not disclosed |
| Plan assumptions | Exchange rate assumption: CNY1 = ¥22.4 |
| Key initiatives | Expand sales and improve profitability in the insulation materials business, Secure adoption and expand sales in the nanomaterials business, Enter new fields, ●Promotion of M&A, Securing human resources |
| Results under the previous plan | The Company stated that results fell below the plan (specific results are Not disclosed). |
| Reason for revision or withdrawal | The projected sales of the Chinese subsidiary declined as the recovery in the Chinese market slowed compared with the initial outlook. In addition, the full-scale adoption of the nanomaterials business's resources and materials, which had been expected in FY46, was postponed to FY47. |
| Risks identified | A slower-than-expected recovery in the Chinese economy, Rising raw material costs in the Chinese market, Continued price competition, The outlook for improved China-US relations, The impact of conflicts in the Middle East, Delays in major furnace repair projects and full-scale adoption resulting from changes to customers' plans and production plans, A significant decline in customers' usage volumes |
| Publication date | 14 May 2026 |
Items this document does not state (9)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The main factors were the slower-than-expected recovery in the Chinese market, which reduced the projected sales of the Chinese subsidiary, and the postponement to the fiscal year ending March 2027 of the full-scale adoption of the company's resources and materials sold through its nanomaterials business for a major project.